Erythrocyte and fasting plasma magnesium were assayed by a dyebinding colorimetric method using the metallochromic dye, Calmagite, in 51 diabetic Nigerians and 25 controls. Erythrocyte magnesium concentrations were similar in the diabetics and the controls. Fasting plasma magnesium concentrations were significantly lower only in insulin-treated diabetics as compared to controls. No significant correlations were observed between fasting plasma glucose concentrations and either plasma or erythrocyte magnesium concentrations in the diabetic groups. Also, no significant correlation was found between erythrocyte magnesium and plasma magnesium concentrations. However, erythrocyte magnesium concentrations were directly related to age while plasma magnesium concentrations were directly related to duration of diabetes in all diabetics. Erythrocyte and plasma magnesium concentrations were not significantly affected by sex and degree of plasma glucose control.
There were 34 men and 17 women with ages ranging from 20 to 65 years (mean 47,1). Thirtythree of the diabetics were non-insulin-treated and on oral hypoglycaemic drugs, while 18 were insulin-treated. Thirteen of the insulin-treated were ketosis-prone. No diabetic patient was on any other drug therapy. In addition, there was no clinical evidence that any had coexisting disease. However, 3 of the patients had varying degrees of retinopathy while a fourth patient had a leg ulcer. The duration of diabetes in all patients, from time of diagnosis to time of study, ranged between 9 months and 25 years (mean 5, 4) .
The control group consisted of 25 healthy nondiabetic subjects, who were members of staff of the hospital. Diabetes was excluded in the controls by urinalysis, estimation of fasting plasma glucose and 2 h post glucose plasma glucose. In addition none of them had symptoms or a family history ofdiabetes mellitus. The ages ranged from 21 to 60 years (mean 41, 8) . No control subject was receiving any drug therapy.
Renal function was normal in all subjects (diabetics and controls). Their magnesium intake, as assessed by dietary recall and based on local standards, was also considered normal.
Magnesium status in Nigerians with diabetus mellitus 75 METHODS Ten millilitres of fasting venous blood was collected from each subject into lithium heparin and fluoride-oxalate containers. Plasma was separated from blood samples within I h of collection and stored at -20°C until analysed, while the red blood cell layer was used subsequently for the preparation of haemolysates for magnesium analysis.
Preparation of haemolysate for erythrocyte magnesium determination
Following separation of plasma from the blood samples, the buffy coat was removed and the bottom layer of red blood cells (RBCs) was washed three times with normal saline. The washed RBCs were then centrifuged at 4000 r.p.m. for 10 min and as much of the supernatant as possible was removed. A packed cell volume determination was carried out on the washed RBCs to assess the completeness of elimination of the supernatant.
Haemolysis of the erythrocytes was achieved bydispersingO·1 mLofwashed RBCs into 1·5 mL of distilled water. Sodium tungstate (0,2 mL; 300 mmol/L) and 0·2 mL of sulphuric acid (350 mrnol/L) were then added. The mixture was then thoroughly stirred with a glass rod. After standing for 5 min the solution was centrifuged for 10 min at 3000 r.p.m. and haemolysate was recovered as the supernatant, for magnesium determination."
Analytical methods
The plasma samples were analysed in batches over a period of 2 days. Each haernolysate for erythrocyte magnesium estimation was processed on the day of its preparation.
Magnesium was analysed by a dye-binding colorimetric method using the metallochromic dye Calmagite.? This method has been found to agree closely with the atomic absorption method." The mean coefficient of variation (CV) for this method, using multilevel quality control samples, is as follows: erythrocyte magnesium ±4·0% and ±4-4%, and plasma magnesium ± 2·9% and ± 3,8%, within and between-batch respectively.
Glucose was analysed by the enzymatic glucose-oxidase method," albumin by the dye-binding method using Bromocresol Green," and creatinine by a reaction kinetic method based on the Jaffe reaction. 11
Statistical methods
A normal distribution of data was confirmed using the Kolmogorov-Smirnov (K-S) test. The data were then processed by the one-way analysis of variance and Student's r-test for unpaired comparisons. Correlation coefficients were calculated using Pearson's linear correlation coefficient. Values are given as mean±SEM. The accepted level of significance was P < 0·05 (twotailed).
Results
The results are summarised in Table I . In addition, when the diabetic patients were separated into three subgroups on the basis of their fasting plasma glucose (FPG) concentrations (i.e. Group I, FPG<7 mmol/L; Group II, FPG 7-10 rnmol/ L; Group III, FPG> 10 mmol/L), magnesium concentrations were similar.
Erythrocyte magnesium correlated positively with age in all the diabetics (r = O' 308,2P < 0,05). Plasma magnesium correlated positively with duration of diabetes, also, in all the diabetics (r=0'281, 2P<0·05). No significant correlations were observed between either fasting plasma glucose or mean plasma glucose (MPG) concentrations (over the previous 6 months) and erythrocyte or plasma magnesium concentrations. Erythrocyte magnesium did not correlate with plasma magnesium in the diabetic patients. Furthermore, no significant sex differences were observed in the concentrations of magnesium in erythrocytes or plasma.
Discussion
This study confirms earlier reports demonstrating significant hypornagnesaemia-:'-" with normal erythrocyte magnesium content4.13.14 in diabetic patients when compared with normal subjects.
The hypomagnesaemia observed in this study was independent of changes in plasma albumin concentration. The tendency towards reduced plasma magnesium was more evident in the insulin-treated group; the decrease observed in the untreated group was not significant.
We have found poor correlation between erythrocyte magnesium and plasma magnesium concentrations in diabetics. Erythrocyte and plasma magnesium concentrations were not significantly affected by the sex of the diabetics, but the two parameters correlated positively with age and duration of diabetes respectively in all the grouped diabetic patients. The positive correlation found between plasma magnesium and duration of diabetes contrasts with findings of other workers showing either an inverse relationship" or lack of any correlation? between the two parameters.
The lack of significant correlation between fasting plasma glucose and plasma magnesium concentrations observed in this study is in agreement with our previous unpublished observations, but contrasts with findings in European diabetics of an inverse relationship between these parameters.v" Even when our diabetic patients were considered separately on the basis of severity of the plasma glucose concentration, no significant changes were observed in magnesium concentrations between the different subgroups. Furthermore, the relationships found between magnesium concentrations and an approximate measure of long-term glycaemic control (i.e. mean of plasma glucose values over the previous six months) were similar to those observed between magnesium concentrations and spot fasting plasma glucose values.
The status of erythrocyte magnesium as an index of body stores is not well defined. 16 Erythrocytes have been observed to respond slowly to changes in body magnesium," but it has been suggested that minute degrees of magnesium deficiency, if prolonged, may cause profound reduction in erythrocyte magnesium. 17 As in erythrocytes, the magnesium content of some other soft tissues such as leucocytes and skeletal muscle have been reported to be normal in diabetic patients.I-" In contrast to results of soft tissue studies, a significant decrease in the trabecular bone magnesium content of insulindependent diabetic patients compared with nondiabetic subjects has been documented. 19 The significance of hypomagnesaemia in diabetes remains largely unsettled. However, hypomagnesaemia has been associated with the development of diabetic retinopathy'v" and it may produce insulin resistance after diabetic ketoacidosis." There is also evidence that magnesium depletion could cause atherogenesis, thus further predisposing diabetic patients to developing ischaemic heart disease.P-"
The findings of the present study suggest that Nigerian diabetics, especially the insulin-treated ones, may develop hypomagnesaemia. This hypomagnesaemia is not associated with depletion of the erythrocyte content of magnesium. Further studies are needed to elucidate precisely the status of magnesium in black African diabetics.
